vs
Acadian Asset Management Inc.（AAMI）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Acadian Asset Management Inc.的1.3倍（$219.9M vs $172.2M），Acadian Asset Management Inc.净利率更高（20.2% vs -1.0%，领先21.2%），Acadian Asset Management Inc.同比增速更快（2.6% vs 2.0%），过去两年Acadian Asset Management Inc.的营收复合增速更高（27.6% vs 8.0%）
Acadian Asset Management Inc.是一家总部位于美国马萨诸塞州波士顿的资产管理机构，专注于为全球机构及个人客户提供专业的投资管理解决方案，在资产管理领域拥有成熟的服务经验与市场布局。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
AAMI vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.3倍
$172.2M
营收增速更快
AAMI
高出0.6%
2.0%
净利率更高
AAMI
高出21.2%
-1.0%
两年增速更快
AAMI
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $172.2M | $219.9M |
| 净利润 | $34.7M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 33.3% | 0.2% |
| 净利率 | 20.2% | -1.0% |
| 营收同比 | 2.6% | 2.0% |
| 净利润同比 | -18.4% | 92.4% |
| 每股收益（稀释后） | $0.97 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AAMIOFIX
| Q4 25 | $172.2M | $219.9M | ||
| Q3 25 | $144.2M | $205.6M | ||
| Q2 25 | $127.4M | $203.1M | ||
| Q1 25 | $119.9M | $193.6M | ||
| Q4 24 | $167.8M | $215.7M | ||
| Q3 24 | $123.1M | $196.6M | ||
| Q2 24 | $109.0M | $198.6M | ||
| Q1 24 | $105.7M | $188.6M |
净利润AAMIOFIX
| Q4 25 | $34.7M | $-2.2M | ||
| Q3 25 | $15.1M | $-22.8M | ||
| Q2 25 | $10.1M | $-14.1M | ||
| Q1 25 | $20.1M | $-53.1M | ||
| Q4 24 | $42.5M | $-29.1M | ||
| Q3 24 | $16.9M | $-27.4M | ||
| Q2 24 | $11.0M | $-33.4M | ||
| Q1 24 | $14.6M | $-36.0M |
毛利率AAMIOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率AAMIOFIX
| Q4 25 | 33.3% | 0.2% | ||
| Q3 25 | 18.4% | -8.3% | ||
| Q2 25 | 12.7% | -7.9% | ||
| Q1 25 | 26.6% | -25.2% | ||
| Q4 24 | 38.7% | -5.3% | ||
| Q3 24 | 21.9% | -9.6% | ||
| Q2 24 | 18.9% | -12.5% | ||
| Q1 24 | 21.7% | -15.6% |
净利率AAMIOFIX
| Q4 25 | 20.2% | -1.0% | ||
| Q3 25 | 10.5% | -11.1% | ||
| Q2 25 | 7.9% | -6.9% | ||
| Q1 25 | 16.8% | -27.4% | ||
| Q4 24 | 25.3% | -13.5% | ||
| Q3 24 | 13.7% | -13.9% | ||
| Q2 24 | 10.1% | -16.8% | ||
| Q1 24 | 13.8% | -19.1% |
每股收益（稀释后）AAMIOFIX
| Q4 25 | $0.97 | $-0.05 | ||
| Q3 25 | $0.42 | $-0.57 | ||
| Q2 25 | $0.28 | $-0.36 | ||
| Q1 25 | $0.54 | $-1.35 | ||
| Q4 24 | $1.11 | $-0.76 | ||
| Q3 24 | $0.45 | $-0.71 | ||
| Q2 24 | $0.29 | $-0.88 | ||
| Q1 24 | $0.37 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | $200.0M | — |
| 股东权益账面价值 | — | $450.0M |
| 总资产 | $677.0M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AAMIOFIX
| Q4 25 | — | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $26.4M | ||
| Q1 24 | — | $27.0M |
总债务AAMIOFIX
| Q4 25 | $200.0M | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $275.0M | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益AAMIOFIX
| Q4 25 | — | $450.0M | ||
| Q3 25 | — | $442.5M | ||
| Q2 25 | — | $458.3M | ||
| Q1 25 | — | $458.3M | ||
| Q4 24 | — | $503.1M | ||
| Q3 24 | — | $525.9M | ||
| Q2 24 | — | $546.0M | ||
| Q1 24 | — | $570.3M |
总资产AAMIOFIX
| Q4 25 | $677.0M | $850.6M | ||
| Q3 25 | $751.4M | $832.6M | ||
| Q2 25 | $672.3M | $837.2M | ||
| Q1 25 | $677.3M | $823.1M | ||
| Q4 24 | $703.2M | $893.3M | ||
| Q3 24 | $555.2M | $867.9M | ||
| Q2 24 | $533.1M | $882.0M | ||
| Q1 24 | $544.9M | $906.0M |
负债/权益比AAMIOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | -0.07× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流AAMIOFIX
| Q4 25 | $-2.4M | $27.7M | ||
| Q3 25 | $-23.9M | $12.4M | ||
| Q2 25 | $61.6M | $11.6M | ||
| Q1 25 | $-48.8M | $-18.4M | ||
| Q4 24 | $55.8M | $23.7M | ||
| Q3 24 | $69.6M | $11.7M | ||
| Q2 24 | $45.7M | $9.0M | ||
| Q1 24 | $-40.4M | $-18.6M |
自由现金流AAMIOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率AAMIOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度AAMIOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率AAMIOFIX
| Q4 25 | -0.07× | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | 6.10× | — | ||
| Q1 25 | -2.43× | — | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | 4.12× | — | ||
| Q2 24 | 4.15× | — | ||
| Q1 24 | -2.77× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AAMI
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
